antibody-drug conjugate abbv-324
Generic: Antibody-drug Conjugate ABBV-324
antibody-drug conjugate abbv-324: 1 clinical trial tracked.
antibody-drug conjugate abbv-324 evidence translation
What we can confirm
1 tracked trial
No verified listed company relationship
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about antibody-drug conjugate abbv-324, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 1 study sponsors
Related indications
Study sponsors
Clinical Trial Registry Records (1)
A Phase 1 First-in-Human Study Evaluating Safety, Pharmacokinetics and Efficacy of ABBV 324 in Adults With Hepatocellular Cancer or Squamous Cell Non-Small Cell Lung Cancer
Primary endpoint: Number of Participants with Adverse Events (AE)s
InterventionalRandomizedopen232 targetStarted 2025-04Completion 2030-0922 sites · China, Israel, Japan, Puerto Rico…AbbVie